ArticleJournal of magnetic resonance imaging : JMRI2020
Clinical Potential of UTE-MRI for Assessing COVID-19: Patient- and Lesion-Based Comparative Analysis.
Article in Journal of magnetic resonance imaging : JMRI, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Contemporary 0.55 T MRI to visualize interstitial lung disease - An exploratory study.European journal of radiology open · 2026Article
- Diffuse cystic lung diseases-a primer for radiologists.BJR open · 2026Review
- Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI.European radiology · 2024Article
- 4D lung MRI with high-isotropic-resolution using half-spoke (UTE) and full-spoke 3D radial acquisition and temporal compressed sensing reconstruction.Physics in medicine and biology · 2023Article
- Which sequence should be used in the thorax magnetic resonance imaging of COVID-19: a comparative study.Turkish journal of medical sciences · 2023Article
- Making the invisible visible-ultrashort echo time magnetic resonance imaging: Technical developments and applications.Applied physics reviews · 2022Review
- COVID-19 pneumonia: lessons learned, challenges, and preparing for the future.Diagnostic and interventional radiology (Ankara, Turkey) · 2022Article
- Post-acute COVID syndrome (long COVID): What should radiographers know and the potential impact for imaging services.Radiography (London, England : 1995) · 2022Review
- [Noninvasive functional lung imaging with hyperpolarized xenon : Breakthrough for diagnostics?]Radiologie (Heidelberg, Germany) · 2022Review
- Inter-Observer Agreement between Low-Dose and Standard-Dose CT with Soft and Sharp Convolution Kernels in COVID-19 Pneumonia.Journal of clinical medicine · 2022Article
- Simultaneous Quantitative Susceptibility Mapping of Articular Cartilage and Cortical Bone of Human Knee Joint Using Ultrashort Echo Time Sequences.Frontiers in endocrinology · 2022Article
- Cross-cultural validation of the IRB Researcher Assessment Tool: Chinese Version.BMC medical ethics · 2021Article
- Covid-19 imaging: A narrative review.Annals of medicine and surgery (2012) · 2021Review
- COVID-19 deep classification network based on convolution and deconvolution local enhancement.Computers in biology and medicine · 2021Article
- Evaluation of injuries caused by coronavirus disease 2019 using multi-nuclei magnetic resonance imaging.Magnetic resonance letters · 2021Review
- Prospective Deployment of Deep Learning in MRI: A Framework for Important Considerations, Challenges, and Recommendations for Best Practices.Journal of magnetic resonance imaging : JMRI · 2021Review
- Imaging of COVID-19: CT, MRI, and PET.Seminars in nuclear medicine · 2021Review
- Imaging in the COVID-19 era: Lessons learned during a pandemic.World journal of radiology · 2021Review
- COVID-19 imaging: Diagnostic approaches, challenges, and evolving advances.World journal of radiology · 2021Review
- Low Dose Chest CT and Lung Ultrasound for the Diagnosis and Management of COVID-19.Journal of clinical medicine · 2021Review
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
backgroundChest computed tomography (CT) has shown tremendous clinical potential for screening, diagnosis, and surveillance of COVID-19. However, safety concerns are warranted due to repeated exposure of X-rays over a short period of time. Recent advances in MRI suggested that ultrashort echo time MRI (UTE-MRI) was valuable for pulmonary applications. PURPOSE: To evaluate the effectiveness of UTE-MRI for assessing COVID-19. STUDY TYPE: Prospective. POPULATION: In all, 23 patients with COVID-19 and with an average interval of 2.81 days between hospital admission and image examination. FIELD STRENGTH/SEQUENCE: 3T; Respiratory-gated three-dimensional radial UTE pulse sequence. ASSESSMENT: Image quality score. Patient- and lesion-based interobserver and intermethod agreement for identifying the representative image findings of COVID-19. STATISTICAL TESTS: Wilcoxon-rank sum test, Kendall's coefficient of concordance (Kendall's W), intraclass coefficients (ICCs), and weighted kappa statistics.
resultsThere was no significant difference between the image quality of CT and UTE-MRI (CT vs. UTE-MRI: 4.3 ± 0.4 vs. 4.0 ± 0.5, P = 0.09). Moreover, both patient- and lesion-based interobserver agreement of CT and UTE-MRI for evaluating the image signs of COVID-19 were determined as excellent (ICC: 0.939-1.000, P < 0.05; Kendall's W: 0.894-1.000, P < 0.05.). In addition, the intermethod agreement of two image modalities for assessing the representative findings of COVID-19 including affected lobes, total severity score, ground glass opacities (GGO), consolidation, GGO with consolidation, the number of crazy paving pattern, and linear opacities, as well as pseudocavity were all determined as substantial or excellent (kappa: 0.649-1.000, P < 0.05; ICC: 0.913-1.000, P < 0.05). DATA
conclusionPulmonary MRI with UTE is valuable for assessing the representative image findings of COVID-19 with a high concordance to CT. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY STAGE: 3 J. Magn. Reson. Imaging 2020;52:397-406.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.